Subsets of animals were sacrificed at 2 weeks post-stroke and 8 weeks post-stroke (end-point) for stereological assessment of FGF-2 expressing cells in the contralesional cortex, which represents the origin of new corticomotor pathways (Fig. 3). This evidence concerns the gene FGF2 and stroke disorder.